BioPharma Credit (LSE:BPCR) 3-Year Book Growth Rate : 0.80% (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit 3-Year Book Growth Rate?

BioPharma Credit's Book Value per Share for the quarter that ended in Dec. 2022 was $1.01.

During the past 12 months, BioPharma Credit's average Book Value per Share Growth Rate was 1.50% per year. During the past 3 years, the average Book Value per Share Growth Rate was 0.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was 0.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of BioPharma Credit was 0.80% per year. The lowest was -0.40% per year. And the median was -0.25% per year.

Competitive Comparison of BioPharma Credit's 3-Year Book Growth Rate

For the Asset Management subindustry, BioPharma Credit's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioPharma Credit's 3-Year Book Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's 3-Year Book Growth Rate falls into.

BioPharma Credit 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

BioPharma Credit (LSE:BPCR) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

BioPharma Credit 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit (LSE:BPCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines